Literature DB >> 23923064

Urothelial eddies in papillary urothelial neoplasms: a distinct morphologic pattern with low risk for progression.

Misung Kim1, Jae Y Ro, Mahul B Amin, Mariza de Peralta-Venturina, Ghee Young Kwon, Yong Wook Park, Yong Mee Cho.   

Abstract

We encountered an undescribed histologic feature of papillary urothelial neoplasms: "urothelial eddy", which was histologically reminiscent of squamous eddy of irritated follicular keratosis of the skin. A review of 756 patients with transurethral resection of bladder tumor revealed 10 patients (1.3%) of papillary urothelial neoplasms with urothelial eddies. All cases were male with a median age of 65 years. Urothelial eddies were characterized by small ovoid nests of ovoid to spindle cells arranged in an onion-skin pattern with fine cytoplasmic processes within wide intercellular space. The cytoplasmic processes mimicked intercellular bridges but ultrastructurally were cytoplasmic microvillous projections. They were of papillary urothelial neoplasm of low malignant potential in seven patients and low-grade urothelial carcinoma in three patients. Nine patients presented as non-invasive tumor and one patient showed microinvasion within papillary stalks. Six patients showed an inverted growth pattern. Their immunoprofile was more similar to that of conventional urothelial carcinoma rather than squamous cell carcinoma: high expressions of GATA3, S100P, uroplakin III, and cytokeratin 7; and low expressions of high molecular weight cytokeratin and p53. The Ki-67 labeling index was low (mean and median values, 2% each). During the follow-up period (mean, 88.7 months), four patients, including the microinvasive patient, showed recurrence with the same grade and stage but neither progressed into muscle-invasive tumor nor caused death. Our results suggest that urothelial eddy is a rare aberrant histology of papillary urothelial neoplasms with indolent behavior and should be discriminated from squamous differentiation of urothelial carcinoma, which has a poor prognosis.

Entities:  

Keywords:  Urothelial carcinoma; indolent; urothelial eddy; variant

Mesh:

Substances:

Year:  2013        PMID: 23923064      PMCID: PMC3726961     

Source DB:  PubMed          Journal:  Int J Clin Exp Pathol        ISSN: 1936-2625


  13 in total

1.  INVERTED FOLLICULAR KERATOSIS.

Authors:  A H MEHREGAN
Journal:  Arch Dermatol       Date:  1964-02

Review 2.  The World Health Organization/International Society of Urological Pathology consensus classification of urothelial (transitional cell) neoplasms of the urinary bladder. Bladder Consensus Conference Committee.

Authors:  J I Epstein; M B Amin; V R Reuter; F K Mostofi
Journal:  Am J Surg Pathol       Date:  1998-12       Impact factor: 6.394

3.  The American Joint Committee on Cancer: the 7th edition of the AJCC cancer staging manual and the future of TNM.

Authors:  Stephen B Edge; Carolyn C Compton
Journal:  Ann Surg Oncol       Date:  2010-06       Impact factor: 5.344

4.  Apoptosis in the areas of squamous differentiation of irritated seborrheic keratosis.

Authors:  C Pesce; S Scalora
Journal:  J Cutan Pathol       Date:  2000-03       Impact factor: 1.587

5.  The effect of squamous and/or glandular differentiation on recurrence, progression and survival in urothelial carcinoma of bladder.

Authors:  Fikret Erdemir; Murat Tunc; Faruk Ozcan; Bekir S Parlaktas; Nihat Uluocak; Isin Kilicaslan; Ozgur Gokce
Journal:  Int Urol Nephrol       Date:  2007-03-02       Impact factor: 2.370

6.  Histologic variants of urothelial bladder cancer and nonurothelial histology in bladder cancer.

Authors:  Venu Chalasani; Joseph L Chin; Jonathan I Izawa
Journal:  Can Urol Assoc J       Date:  2009-12       Impact factor: 1.862

Review 7.  Histological variants of urothelial carcinoma: diagnostic, therapeutic and prognostic implications.

Authors:  Mahul B Amin
Journal:  Mod Pathol       Date:  2009-06       Impact factor: 7.842

Review 8.  The impact of variant histology on the outcome of bladder cancer treated with curative intent.

Authors:  Peter C Black; Gordon A Brown; Colin P N Dinney
Journal:  Urol Oncol       Date:  2008-01-14       Impact factor: 3.498

9.  The role of squamous differentiation in patients with transitional cell carcinoma of the bladder treated with radical cystectomy.

Authors:  Alberto A Antunes; Luciano J Nesrallah; Marcos F Dall'Oglio; Carlos E Maluf; Cesar Camara; Katia R Leite; Miguel Srougi
Journal:  Int Braz J Urol       Date:  2007 May-Jun       Impact factor: 1.541

10.  Potential utility of uroplakin III, thrombomodulin, high molecular weight cytokeratin, and cytokeratin 20 in noninvasive, invasive, and metastatic urothelial (transitional cell) carcinomas.

Authors:  Douglas C Parker; Andrew L Folpe; Julie Bell; Esther Oliva; Robert H Young; Cynthia Cohen; Mahul B Amin
Journal:  Am J Surg Pathol       Date:  2003-01       Impact factor: 6.394

View more
  3 in total

1.  Synaptophysin, CD117, and GATA3 as a Diagnostic Immunohistochemical Panel for Small Cell Neuroendocrine Carcinoma of the Urinary Tract.

Authors:  Gi Hwan Kim; Yong Mee Cho; So-Woon Kim; Ja-Min Park; Sun Young Yoon; Gowun Jeong; Dong-Myung Shin; Hyein Ju; Se Un Jeong
Journal:  Cancers (Basel)       Date:  2022-05-19       Impact factor: 6.575

2.  Overexpression of the PPAR-γ protein in primary Ta/T1 non-muscle-invasive urothelial carcinoma.

Authors:  Shinichi Tanaka; Yasunori Tokuhara; Sho Hosokawa; Hiroyuki Ohsaki; Tatsuya Morinishi; Tamami Yamamoto; Norihiro Teramoto; Eiichiro Hirakawa
Journal:  Mol Clin Oncol       Date:  2021-12-16

3.  Association Between Estrogen Receptors and GATA3 in Bladder Cancer: A Systematic Review and Meta-Analysis of Their Clinicopathological Significance.

Authors:  Carina Bernardo; Fátima L Monteiro; Inês Direito; Francisco Amado; Vera Afreixo; Lúcio L Santos; Luisa A Helguero
Journal:  Front Endocrinol (Lausanne)       Date:  2021-10-08       Impact factor: 5.555

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.